Skip to main content

MoneyWorks4Me

Divi's Laboratories informs about updates

24 May 2025 Evaluate

Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, Divi's Laboratories has submitted the details as required under Para B of Part A of Schedule III of the Regulations read Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1778.25
Dr. Reddys Labs. 1350.20
Cipla 1380.00
Lupin 2009.00
Zydus Lifesciences 1244.00
View more..